Entrada Therapeutics
TRDA
#6372
Rank
S$0.71 B
Marketcap
$19.12
Share price
-2.13%
Change (1 day)
-1.49%
Change (1 year)

Entrada Therapeutics (TRDA) - Cash on Hand

Cash on Hand as of June 2024 : S$0.61 B

According to Entrada Therapeutics's latest financial reports the company has S$0.61 B in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Entrada Therapeutics - Cash on Hand chart (from 2020 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31S$0.46 B83.74%
2022-12-31S$0.25 B-35.55%
2021-12-31S$0.39 B660.43%
2020-12-31S$51.61 M127.9%
2019-12-31S$22.65 M